FDA NDC Directory · JSON-LD · Markdown

KEYTRUDA

NDC 0006-3026 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namepembrolizumab
Labeler / ManufacturerMerck Sharp & Dohme LLC
Marketing categoryBiologic License Application · App BLA125514
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsPEMBROLIZUMAB (25 mg/mL)
Marketing started20150115
Package count2

External sources

Source: openFDA. Public-domain (CC0).